GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Inc (ROCO:6892) » Definitions » Net Change in Cash

Taiwan Bio Therapeutics (ROCO:6892) Net Change in Cash : NT$16.5 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Taiwan Bio Therapeutics Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Taiwan Bio Therapeutics's Net Change in Cash for the three months ended in Jun. 2024 was NT$190.5 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was NT$16.5 Mil.

Taiwan Bio Therapeutics Net Change in Cash Historical Data

The historical data trend for Taiwan Bio Therapeutics's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Bio Therapeutics Net Change in Cash Chart

Taiwan Bio Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
6.62 13.96 23.20 186.19 2.25

Taiwan Bio Therapeutics Quarterly Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only 309.04 -122.85 178.66 -174.00 190.54

Taiwan Bio Therapeutics Net Change in Cash Calculation

Taiwan Bio Therapeutics's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-166.546+-119.227+290.432+-2.412
=2.2

Taiwan Bio Therapeutics's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-93.461+-106.107+389.918+0.194
=190.5

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$16.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiwan Bio Therapeutics Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Taiwan Bio Therapeutics's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Bio Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Inc (ROCO:6892) » Definitions » Net Change in Cash
Comparable Companies
ROCO:7754 TPE:1762 ROCO:6676 TPE:1733 ROCO:4130 ROCO:4168 ROCO:6580 ROCO:6704 ROCO:6926 ROCO:1295 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Tiding Avenue, 5th Floor, No. 501, Section 2, Neihu District, Zhubei, TWN, 114744
Website
https://www.twbio-thera.com
Taiwan Bio Therapeutics Inc is a regenerative medicine company specializing in the development of new genetically modified cell drugs. It is providing commissioned development and manufacturing (CDMO/CMO) services and inspection, analysis and development services for cellular medical products.

Taiwan Bio Therapeutics Headlines

No Headlines